Expanded role for ARBs in cardiovascular and renal disease?: Recent observations have far-reaching implications: Postgraduate Medicine: Vol 109, No 4

Views

CrossRef citations to date

Altmetric

PREVIEW

Angiotensin II receptor blockers (ARBs) are effective antihypertensive agents that act by selectively inhibiting the AT₁ subtype of the angiotensin II receptors. In this article, Dr Ramahi discusses the mechanisms of action for these medications and their potential role in the prevention and treatment of chronic heart failure (CHF), atherosclerotic arterial disease, post-myocardial infarction state, and chronic renal failure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Expanded role for ARBs in cardiovascular and renal disease?

Recent observations have far-reaching implications

Information for

Open access

Opportunities

Help and information

Expanded role for ARBs in cardiovascular and renal disease?

Recent observations have far-reaching implications

PREVIEW

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature